TY - JOUR
T1 - Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform
AU - Khakhum, Nittaya
AU - Baruch-Torres, Noe
AU - Stockton, Jacob L.
AU - Chapartegui-González, Itziar
AU - Badten, Alexander J.
AU - Adam, Awadalkareem
AU - Wang, Tian
AU - Huerta-Saquero, Alejandro
AU - Whitney Yin, Y.
AU - Torres, Alfredo G.
N1 - Publisher Copyright:
Copyright © 2024 American Society for Microbiology. All Rights Reserved.
PY - 2024/3
Y1 - 2024/3
N2 - Virus-like particles (VLPs) are protein-based nanoparticles frequently used as carriers in conjugate vaccine platforms. VLPs have been used to display foreign antigens for vaccination and to deliver immunotherapy against diseases. Hemolysin-coregulated proteins 1 (Hcp1) is a protein component of the Burkholderia type 6 secretion system, which participates in intracellular invasion and dissemination. This protein has been reported as a protective antigen and is used in multiple vaccine candidates with various platforms against melioidosis, a severe infectious disease caused by the intracellular pathogen Burkholderia pseudomallei. In this study, we used P22 VLPs as a surface platform for decoration with Hcp1 using chemical conjugation. C57BL/6 mice were intranasally immunized with three doses of either PBS, VLPs, or conjugated Hcp1-VLPs. Immunization with Hcp1-VLPs formulation induced Hcp1-specific IgG, IgG1, IgG2c, and IgA antibody responses. Furthermore, the serum from Hcp1-VLPs immunized mice enhanced the bacterial uptake and opsonophagocytosis by macrophages in the presence of complement. This study demonstrated an alternative strategy to develop a VLPs-based vaccine platform against Burkholderia species.
AB - Virus-like particles (VLPs) are protein-based nanoparticles frequently used as carriers in conjugate vaccine platforms. VLPs have been used to display foreign antigens for vaccination and to deliver immunotherapy against diseases. Hemolysin-coregulated proteins 1 (Hcp1) is a protein component of the Burkholderia type 6 secretion system, which participates in intracellular invasion and dissemination. This protein has been reported as a protective antigen and is used in multiple vaccine candidates with various platforms against melioidosis, a severe infectious disease caused by the intracellular pathogen Burkholderia pseudomallei. In this study, we used P22 VLPs as a surface platform for decoration with Hcp1 using chemical conjugation. C57BL/6 mice were intranasally immunized with three doses of either PBS, VLPs, or conjugated Hcp1-VLPs. Immunization with Hcp1-VLPs formulation induced Hcp1-specific IgG, IgG1, IgG2c, and IgA antibody responses. Furthermore, the serum from Hcp1-VLPs immunized mice enhanced the bacterial uptake and opsonophagocytosis by macrophages in the presence of complement. This study demonstrated an alternative strategy to develop a VLPs-based vaccine platform against Burkholderia species.
KW - B. pseudomallei
KW - Hcp1
KW - P22-based nanovaccines
KW - melioidosis
KW - type 6 secretion system
KW - virus-like particles
UR - http://www.scopus.com/inward/record.url?scp=85187723544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85187723544&partnerID=8YFLogxK
U2 - 10.1128/iai.00019-24
DO - 10.1128/iai.00019-24
M3 - Article
C2 - 38353543
AN - SCOPUS:85187723544
SN - 0019-9567
VL - 92
JO - Infection and immunity
JF - Infection and immunity
IS - 3
ER -